Barbara Klencke

Insider Reports History

Location
Pasadena, CA
Signature
/s/ Shelly Pinto, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Klencke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TScan Therapeutics, Inc. Director Voting Common Stock 45K $238K $5.29 23 Sep 2024 Direct
Xencor Inc Director Common Stock 19.7K $207K $10.51 12 Jun 2025 Direct
TScan Therapeutics, Inc. Director Voting Common Stock 25K $132K $5.29 23 Sep 2024 By Trust
ALX ONCOLOGY HOLDINGS INC Director Common Stock 60K $108K $1.80 21 Jan 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Common Stock 60K $108K $1.80 21 Jan 2025 Indirect
ALX ONCOLOGY HOLDINGS INC Director Stock option (right to buy) 300K 17 Sep 2025 Direct
TScan Therapeutics, Inc. Director Stock Option (Right to Buy) 67K 30 Jun 2025 Direct
Xencor Inc Director Stock Option (Right to Buy) 27.4K 12 Jun 2025 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 13 Jun 2024 Direct
Sierra Oncology, Inc. Chief Medical Officer Common Stock 0 $55.00 01 Jul 2022 By spouse
Sierra Oncology, Inc. Chief Medical Officer Common Stock 0 $55.00 01 Jul 2022 Direct
Sierra Oncology, Inc. Chief Medical Officer Stock Option (right to buy) 0 01 Jul 2022 Direct

Insider Reports Filed by Barbara Klencke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALXO ALX ONCOLOGY HOLDINGS INC 17 Sep 2025 1 $0 4 Director 19 Sep 2025, 16:01
TCRX TScan Therapeutics, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 16:32
XNCR Xencor Inc 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 19:33
ALXO ALX ONCOLOGY HOLDINGS INC 21 Jan 2025 1 $0 4 Director 23 Jan 2025, 18:24
ALXO ALX ONCOLOGY HOLDINGS INC 21 Jan 2025 0 $0 3 Director 23 Jan 2025, 18:22
TCRX TScan Therapeutics, Inc. 23 Sep 2024 1 $26.5K 4 Director 24 Sep 2024, 17:26
TCRX TScan Therapeutics, Inc. 23 Aug 2024 2 $56.1K 4 Director 27 Aug 2024, 18:57
XNCR Xencor Inc 13 Jun 2024 2 $0 4 Director 17 Jun 2024, 16:25
EFTR eFFECTOR Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 18:35
TCRX TScan Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:20
EFTR eFFECTOR Therapeutics, Inc. 19 Feb 2024 1 $0 4 Director 21 Feb 2024, 17:22
TCRX TScan Therapeutics, Inc. 14 Dec 2023 1 $25.4K 4 Director 18 Dec 2023, 18:01
XNCR Xencor Inc 15 Sep 2023 1 $0 4 Director 19 Sep 2023, 17:32
XNCR Xencor Inc 15 Sep 2023 0 $0 3 Director 19 Sep 2023, 17:30
EFTR eFFECTOR Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:14
TCRX TScan Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:13
TCRX TScan Therapeutics, Inc. 06 Apr 2023 1 $0 4 Director 10 Apr 2023, 10:39
TCRX TScan Therapeutics, Inc. 06 Apr 2023 0 $0 3 Director 10 Apr 2023, 10:35
EFTR eFFECTOR Therapeutics, Inc. 20 Jan 2023 1 $0 4 Director 24 Jan 2023, 15:10
SRRA Sierra Oncology, Inc. 01 Jul 2022 12 -$825K 4 Chief Medical Officer 01 Jul 2022, 16:43
SRRA Sierra Oncology, Inc. 17 Jun 2022 1 $0 4 Chief Medical Officer 17 Jun 2022, 16:14
EFTR eFFECTOR Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 18:49
SRRA Sierra Oncology, Inc. 14 Mar 2022 1 $0 4 Chief Medical Officer 14 Mar 2022, 16:45
SRRA Sierra Oncology, Inc. 28 Jan 2022 1 $0 4 Chief Medical Officer 28 Jan 2022, 17:34
EFTR eFFECTOR Therapeutics, Inc. 01 Nov 2021 1 $0 4 Director 02 Nov 2021, 19:10
EFTR eFFECTOR Therapeutics, Inc. 01 Nov 2021 0 $0 3 Director 02 Nov 2021, 19:06